Respiratory physicians are hopeful there might be some relaxation of the current requirement to wait six months before transferring patients with severe asthma from one biologic to another. The PBAC, which met with key stakeholders including industry representatives in December 2018, have recently made public the meeting outcome statement. It says the six-month treatment break ...
Already a member?
Enter your email to keep reading.